Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Certain gene variations increase the risk of alopecia areata in Koreans.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

CD2 might be a new treatment target for patchy alopecia areata.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Hominis Placenta Pharmacopunture helped regrow hair in a patient with stress-induced hair loss.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Early recognition and treatment of atypical alopecia areata in infants are crucial.